Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Target 64+ ounces daily
Pricing comparison: Key differences: Compounded tirzepatide is not FDA-approved It's prepared by a state-licensed 503A or 503B compounding pharmacy It's drawn from a vial with a syringe rather than delivered via auto-injector pen It's available without insurance, prior authorization, or formulary restrictions It cannot be billed to Medicare Part D When compounded makes financial sense: If your Part D copay exceeds $280 per month, compounded tirzepatide at $279 monthly is cheaper
Rare but Serious: Aseptic Meningitis Although uncommon, IVIG can occasionally trigger aseptic meningitis, an inflammation of the protective membranes surrounding the brain and spinal cord that is not caused by a bacterial infection
A: The recommended dosage for adults is 10-30 ml daily
Weight Loss Outcomes: Clinical Trial Data and Real-World Results Pivotal trials for tirzepatide (SURMOUNT program) demonstrated average weight loss ranging from 16% to 21% of baseline body weight across three dose levels over 68 weeks
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
